Skip navigation
Merrion pharmaceuticals - making medicines better
Skip navigation

Regulatory News

03 Febuary 2012

Merrion Pharmaceuticals Board Resignation

Merrion Pharmaceuticals plc (ESM: MERR), announced today that Non-Executive Director Paddy O'Sullivan has resigned from the Board of Directors with effect from 29 February 2012. Merrion Chairman, Michael Donnelly commented: "On behalf of the Merrion Board and the senior management team, I would like to thank Paddy O'Sulllivan for his significant contribution to Merrion over the past 4 years and to wish him every success in the future."


Investor Enquiries:

Merrion Pharmaceuticals Plc.
Jonathan O'Connell
T +353 1 642 3300

Davy Corporate Finance
Ivan Murphy
T +353 1 679 6363

Media Enquiries:

Slattery Communications
Conor Dempsey
T +353 86 247 9892


<< Back to Regulatory News